Cargando…
Determining the Antibiofilm Efficacy of Oregano Gel in an Ex Vivo Model of Percutaneous Osseointegrated Implants
Biofilm contamination is common in patients with percutaneous osseointegrated (OI) implants, leading to frequent infections, irritation, and discomfort. Reported infection rates soar up to 65% as the recalcitrant nature of biofilms complicates treatment. There is persistent need for therapies to man...
Autores principales: | Ong, Jemi, Godfrey, Rose, Isaacson, Brad, Pasquina, Paul, Williams, Dustin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696298/ https://www.ncbi.nlm.nih.gov/pubmed/36363725 http://dx.doi.org/10.3390/microorganisms10112133 |
Ejemplares similares
-
An antimicrobial blue light device to manage infection at the skin-implant interface of percutaneous osseointegrated implants
por: Ong, Jemi, et al.
Publicado: (2023) -
Comparison of Staphylococcus aureus tolerance between antimicrobial blue light, levofloxacin, and rifampin
por: Ong, Jemi, et al.
Publicado: (2023) -
Ex vivo comparison of V.A.C.® Granufoam Silver™ and V.A.C.® Granufoam™ loaded with a first-in-class bis-dialkylnorspermidine-terphenyl antibiofilm agent
por: Rawson, Kaden B., et al.
Publicado: (2023) -
In vivo efficacy of a unique first-in-class antibiofilm antibiotic for biofilm-related wound infections caused by Acinetobacter baumannii
por: Williams, Dustin L., et al.
Publicado: (2020) -
A Method for the Evaluation of Early Osseointegration of Implant Materials Ex Vivo: Human Bone Organ Model
por: Zankovic, Sergej, et al.
Publicado: (2021)